Torrent Pharma vs Zydus Lifesciences: share price, P/E, ROE and financials compared
Torrent Pharmaceuticals
Zydus Lifesciences
Torrent Pharma and Zydus Lifesciences at a glance
Torrent Pharma and Zydus Lifesciences are both listed in Healthcare. Torrent Pharma is the larger by market cap, at ₹1.8L Cr against ₹1.2L Cr for Zydus Lifesciences (1.5 times as large). On valuation, Zydus Lifesciences has the lower P/E (28.6× against 80.2×) and the lower price-to-book (4.29× against 9.83×). On returns and margins, Torrent Pharma has the higher ROE (15.7% against 14.7%) and the higher operating margin (33.7% against 26.2%), while Zydus Lifesciences has the higher ROCE (19.0% against 9.1%). Over three years, Zydus Lifesciences has faster 3-year sales growth (+16.5% against +13.3% a year) and faster 3-year profit growth (+37.0% against +20.2% a year). Zydus Lifesciences carries less debt for its equity, with a debt-to-equity of 0.46× against 0.77×.
Key metrics, side by side
| Metric | Torrent PharmaTORNTPHARM | Zydus LifesciencesZYDUSLIFE |
|---|---|---|
| Price (₹) | 4,750.00 | 1,197.90 |
| Market cap (₹ Cr) | 1,80,675 | 1,19,491 |
| P/E | 80.2× | 28.6× (the lower figure, shaded) |
| P/B | 9.83× | 4.29× (the lower figure, shaded) |
| Dividend yield, trailing | 0.80% (the higher figure, shaded) | 0.08% |
| ROE | 15.7% (the higher figure, shaded) | 14.7% |
| ROCE | 9.1% | 19.0% (the higher figure, shaded) |
| Operating margin (OPM) | 33.7% (the higher figure, shaded) | 26.2% |
| Net margin (NPM) | 12.2% | 13.8% (the higher figure, shaded) |
| Sales CAGR 3Y | +13.3% | +16.5% (the higher figure, shaded) |
| Profit CAGR 3Y | +20.2% | +37.0% (the higher figure, shaded) |
| Debt to equity | 0.77× | 0.46× (the lower figure, shaded) |
| Interest cover | 8.5× | 19.1× (the higher figure, shaded) |
| Net profit TTM (₹ Cr) | 2,124 | – |
| 1Y return | +31.7% (the higher figure, shaded) | +22.8% |
| Promoter holding | 60.78% | – |
Torrent Pharma vs Zydus Lifesciences: common questions
Which is bigger, Torrent Pharma or Zydus Lifesciences?
By market cap, Torrent Pharma is bigger at ₹1.8L Cr, against ₹1.2L Cr for Zydus Lifesciences (prices as of 6 Nov 2026).
Which has a lower P/E ratio, Torrent Pharma or Zydus Lifesciences?
Torrent Pharma trades at a P/E of 80.2× and Zydus Lifesciences at 28.6×. Zydus Lifesciences has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Torrent Pharma or Zydus Lifesciences?
Torrent Pharma reports a return on equity of 15.7% and Zydus Lifesciences 14.7%. Torrent Pharma has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Torrent Pharma or Zydus Lifesciences?
Over the last three years: Sales grew +13.3% a year at Torrent Pharma and +16.5% at Zydus Lifesciences, so Zydus Lifesciences grew sales faster; profit grew +20.2% a year at Torrent Pharma and +37.0% at Zydus Lifesciences, so Zydus Lifesciences grew profit faster. Past growth doesn’t predict future growth.